Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,740
-100 (-0.72%)
At close: Mar 28, 2025, 3:30 PM KST

Daewon Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
14,21023,91731,9446,98917,640
Upgrade
Depreciation & Amortization
20,09517,56119,36817,80515,674
Upgrade
Loss (Gain) From Sale of Assets
-25.42-149.95-45.710.86-2.34
Upgrade
Asset Writedown & Restructuring Costs
4,6714,5972,1541,111715.77
Upgrade
Loss (Gain) From Sale of Investments
1,14961.5752.76870.39-1,990
Upgrade
Loss (Gain) on Equity Investments
-704.2-509.42-860.08-382.62-517.27
Upgrade
Provision & Write-off of Bad Debts
-204.13230.88887.59-250.26-171.71
Upgrade
Other Operating Activities
17,84010,63813,24013,0547,952
Upgrade
Change in Accounts Receivable
-2,504-7,949-11,075-11,2783,819
Upgrade
Change in Inventory
-6,642-15,837-23,989-4,075-13,944
Upgrade
Change in Accounts Payable
1,041938.612,107-1,4451,559
Upgrade
Change in Income Taxes
3.21-2.035.05-0.320.49
Upgrade
Change in Other Net Operating Assets
-18,89418,239-8,07514.07-5,784
Upgrade
Operating Cash Flow
30,03551,73426,41322,41324,951
Upgrade
Operating Cash Flow Growth
-41.94%95.86%17.85%-10.17%-19.43%
Upgrade
Capital Expenditures
-34,864-12,289-8,009-4,104-11,346
Upgrade
Sale of Property, Plant & Equipment
778.66204.25504.445.1642.79
Upgrade
Cash Acquisitions
-7.62---14,602-
Upgrade
Sale (Purchase) of Intangibles
-18,218-8,322-5,357-7,603-4,038
Upgrade
Investment in Securities
-12,380-893.53-9,055-16,256-33.31
Upgrade
Other Investing Activities
21,020-47,3311,520562.08556.22
Upgrade
Investing Cash Flow
-42,975-68,267-20,775-41,615-14,893
Upgrade
Short-Term Debt Issued
60,42120,08130027,069-
Upgrade
Long-Term Debt Issued
42,00022,0003,35245,920-
Upgrade
Total Debt Issued
102,42142,0813,65272,989-
Upgrade
Short-Term Debt Repaid
-45,000-234.39-468.76-10,063-
Upgrade
Long-Term Debt Repaid
-42,958-10,666-10,062-9,479-1,228
Upgrade
Total Debt Repaid
-87,958-10,900-10,530-19,541-1,228
Upgrade
Net Debt Issued (Repaid)
14,46331,181-6,87853,448-1,228
Upgrade
Issuance of Common Stock
-106.64-210.31-
Upgrade
Repurchase of Common Stock
---6,171-85.84-5,062
Upgrade
Dividends Paid
-6,359-7,340-4,120-3,140-5,035
Upgrade
Other Financing Activities
-8,402-4,434-3,241-1,906-1,260
Upgrade
Financing Cash Flow
-297.8119,513-20,41148,527-12,584
Upgrade
Foreign Exchange Rate Adjustments
312.2232.0945.2640.01-39.13
Upgrade
Miscellaneous Cash Flow Adjustments
---1,893-
Upgrade
Net Cash Flow
-12,9263,013-14,72731,258-2,565
Upgrade
Free Cash Flow
-4,82939,44618,40518,30913,605
Upgrade
Free Cash Flow Growth
-114.32%0.52%34.58%-
Upgrade
Free Cash Flow Margin
-0.81%7.49%3.84%5.17%4.41%
Upgrade
Free Cash Flow Per Share
-249.801880.17841.34862.87637.47
Upgrade
Cash Interest Paid
6,5134,4213,2301,8581,255
Upgrade
Cash Income Tax Paid
4,8215,2117,5228,92210,086
Upgrade
Levered Free Cash Flow
-28,2022,59010,19614,8433,209
Upgrade
Unlevered Free Cash Flow
-22,3865,47412,49816,1423,948
Upgrade
Change in Net Working Capital
6,07111,62220,3192,02211,328
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.